Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 680
Testing effectiveness (Phase 2)Study completedNCT01466036What this trial is testingCabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid TumorsWho this might be right forCarcinoid TumorPancreatic Neuroendocrine Tumor Dana-Farber Cancer Institute 61
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT05247905What this trial is testingComparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialWho this might be right forMetastatic Pancreatic Neuroendocrine TumorUnresectable Pancreatic Neuroendocrine Carcinoma Alliance for Clinical Trials in Oncology 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Not applicableEnded earlyNCT03947762What this trial is testingLanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.Who this might be right forPancreatic Neuroendocrine Tumor Ipsen 54
Not applicableUnknownNCT04066322What this trial is testingResection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System TreatmentWho this might be right forNeuroendocrine TumorsMetastasesSurgery Fudan University 180
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Large-scale testing (Phase 3)Active Not RecruitingNCT03375320What this trial is testingTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsWho this might be right forFunctioning Pancreatic Neuroendocrine TumorIntermediate Grade Lung Neuroendocrine NeoplasmLocally Advanced Digestive System Neuroendocrine Neoplasm+25 more National Cancer Institute (NCI) 298
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)UnknownNCT01882946What this trial is testingSafety and Efficacy Study of DCVax-Direct in Solid TumorsWho this might be right forLocally Advanced TumorMetastatic Solid Tissue TumorsLiver Cancer+3 more Northwest Biotherapeutics 60
Testing effectiveness (Phase 2)UnknownNCT04913337What this trial is testingStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMesotheliomaGlioblastomaRenal Cell Carcinoma+12 more NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Study completedNCT02651987What this trial is testingEfficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mgWho this might be right forPancreatic TumoursMidgut Neuroendocrine Tumours Ipsen 99
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Large-scale testing (Phase 3)Looking for participantsNCT06943755What this trial is testingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsWho this might be right forPancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET) Exelixis 440
Not applicableActive Not RecruitingNCT04584008What this trial is testingTargeted Agent Evaluation in Digestive Cancers in China Based on Molecular CharacteristicsWho this might be right forBiliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more Peking University 600